FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011346605> ?p ?o ?g. }

• W2011346605 endingPage "43" @default.
• W2011346605 startingPage "31" @default.
• W2011346605 abstract "Objective: Using systematic review methodology, we endeavored to answer the following questions concerning the treatment of osteochondral pathology: (1) what pathologies have been treated in vivo with the use of platelet-rich plasma (PRP); (2) what methods of PRP preparation and delivery have been reported; (3) what assessment tools and comparison group have been used to assess its effectiveness; and (4) what are the clinical outcomes of its use. Data Sources: A systematic literature search was performed of the OVID, EMBASE, and Evidence Based Medicine Reviews databases to identify all studies published up to October 2012 that assessed clinical outcomes of the use of PRP for the treatment of chondral and osteochondral pathology, excluding those including concomitant management of acute fractures or ligament reconstruction. Data Extraction: The included studies were reviewed and the following data were extracted and tabulated: study authors' year and journal, study design and level of evidence, pathology treated, methods of PRP preparation and delivery, and clinical outcome scores. Data Synthesis: Ten studies were included in the final analysis. The majority of studies assessed the use of PRP in the treatment of degenerative osteoarthritis of the knee or hip (representing 570 of a total of 662 joints). The majority of patients were treated with intra-articular injections, whereas 2 studies used PRP as an adjunct to surgical treatment. Significant improvements in joint-specific clinical scores (7 of 8 studies), general health scores (4 of 4 studies), and pain scores (4 of 6 studies) compared with baseline were reported up to 6-month follow-up, but few studies provided longer-term data. No studies reported worse scores compared with baseline at final follow-up. Three of 4 comparative studies reported significantly better clinical and/or pain scores when compared with hyaluronic acid injections at similar follow-up times. Conclusions: Currently, there is a paucity of data supporting the use of PRP for the management of focal traumatic osteochondral defects. There is limited evidence suggesting short-term clinical benefits with the use of PRP for symptomatic osteoarthritis of the knee, but the studies published to date are of poor quality and at high risk for bias. Further high-quality comparative studies with longer follow-up are needed to ascertain whether PRP is beneficial, either alone or as an adjunct to surgical procedures, in the management of articular cartilage pathology." @default.
• W2011346605 created "2016-06-24" @default.
• W2011346605 creator A5008119695 @default.
• W2011346605 creator A5008149778 @default.
• W2011346605 creator A5016619046 @default.
• W2011346605 creator A5033970547 @default.
• W2011346605 creator A5081883425 @default.
• W2011346605 date "2014-01-01" @default.
• W2011346605 modified "2023-10-18" @default.
• W2011346605 title "Platelet-Rich Plasma in the Management of Articular Cartilage Pathology" @default.
• W2011346605 cites W104176905 @default.
• W2011346605 cites W1237294289 @default.
• W2011346605 cites W152900794 @default.
• W2011346605 cites W163550638 @default.
• W2011346605 cites W1981003717 @default.
• W2011346605 cites W1984196156 @default.
• W2011346605 cites W1991596608 @default.
• W2011346605 cites W2006050540 @default.
• W2011346605 cites W2012504160 @default.
• W2011346605 cites W2019055276 @default.
• W2011346605 cites W2020466745 @default.
• W2011346605 cites W2025603090 @default.
• W2011346605 cites W2034632069 @default.
• W2011346605 cites W2042001009 @default.
• W2011346605 cites W2052535861 @default.
• W2011346605 cites W2054295086 @default.
• W2011346605 cites W2062156568 @default.
• W2011346605 cites W2067079430 @default.
• W2011346605 cites W2081602516 @default.
• W2011346605 cites W2086318913 @default.
• W2011346605 cites W2094346517 @default.
• W2011346605 cites W2098532744 @default.
• W2011346605 cites W2098923148 @default.
• W2011346605 cites W2103555639 @default.
• W2011346605 cites W2111579522 @default.
• W2011346605 cites W2112339576 @default.
• W2011346605 cites W2114407151 @default.
• W2011346605 cites W2116532299 @default.
• W2011346605 cites W2119145361 @default.
• W2011346605 cites W2125605937 @default.
• W2011346605 cites W2141157018 @default.
• W2011346605 cites W2149781582 @default.
• W2011346605 cites W2164816019 @default.
• W2011346605 cites W4247904109 @default.
• W2011346605 cites W4297755929 @default.
• W2011346605 doi "https://doi.org/10.1097/01.jsm.0000432855.85143.e5" @default.
• W2011346605 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24231930" @default.
• W2011346605 hasPublicationYear "2014" @default.
• W2011346605 type Work @default.
• W2011346605 sameAs 2011346605 @default.
• W2011346605 citedByCount "49" @default.
• W2011346605 countsByYear W20113466052014 @default.
• W2011346605 countsByYear W20113466052015 @default.
• W2011346605 countsByYear W20113466052016 @default.
• W2011346605 countsByYear W20113466052017 @default.
• W2011346605 countsByYear W20113466052018 @default.
• W2011346605 countsByYear W20113466052019 @default.
• W2011346605 countsByYear W20113466052020 @default.
• W2011346605 countsByYear W20113466052021 @default.
• W2011346605 countsByYear W20113466052022 @default.
• W2011346605 crossrefType "journal-article" @default.
• W2011346605 hasAuthorship W2011346605A5008119695 @default.
• W2011346605 hasAuthorship W2011346605A5008149778 @default.
• W2011346605 hasAuthorship W2011346605A5016619046 @default.
• W2011346605 hasAuthorship W2011346605A5033970547 @default.
• W2011346605 hasAuthorship W2011346605A5081883425 @default.
• W2011346605 hasConcept C105702510 @default.
• W2011346605 hasConcept C126322002 @default.
• W2011346605 hasConcept C141071460 @default.
• W2011346605 hasConcept C142724271 @default.
• W2011346605 hasConcept C17744445 @default.
• W2011346605 hasConcept C1862650 @default.
• W2011346605 hasConcept C189708586 @default.
• W2011346605 hasConcept C19648533 @default.
• W2011346605 hasConcept C199539241 @default.
• W2011346605 hasConcept C204787440 @default.
• W2011346605 hasConcept C2776164576 @default.
• W2011346605 hasConcept C2777466982 @default.
• W2011346605 hasConcept C2779384505 @default.
• W2011346605 hasConcept C2779473830 @default.
• W2011346605 hasConcept C2780076745 @default.
• W2011346605 hasConcept C2780550940 @default.
• W2011346605 hasConcept C3020332539 @default.
• W2011346605 hasConcept C535046627 @default.
• W2011346605 hasConcept C71924100 @default.
• W2011346605 hasConcept C89560881 @default.
• W2011346605 hasConceptScore W2011346605C105702510 @default.
• W2011346605 hasConceptScore W2011346605C126322002 @default.
• W2011346605 hasConceptScore W2011346605C141071460 @default.
• W2011346605 hasConceptScore W2011346605C142724271 @default.
• W2011346605 hasConceptScore W2011346605C17744445 @default.
• W2011346605 hasConceptScore W2011346605C1862650 @default.
• W2011346605 hasConceptScore W2011346605C189708586 @default.
• W2011346605 hasConceptScore W2011346605C19648533 @default.
• W2011346605 hasConceptScore W2011346605C199539241 @default.
• W2011346605 hasConceptScore W2011346605C204787440 @default.
• W2011346605 hasConceptScore W2011346605C2776164576 @default.
• W2011346605 hasConceptScore W2011346605C2777466982 @default.

• next